Journal article icon

Journal article

Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.

Abstract:

BACKGROUND: Granulocyte-colony stimulating factor (G-CSF) reduces the risk of severe neutropenia associated with chemotherapy, but its cost implications following chemotherapy are unknown. OBJECTIVE: Our objective was to examine associations between G-CSF use and medical costs after initial adjuvant chemotherapy in early-stage (stage I-III) breast cancer (ESBC). METHODS: Women diagnosed with ESBC from 1999 to 2005, who had an initial course of chemotherapy beginning within 180 days of diagno...

Expand abstract

Actions


Access Document


Authors


Griffiths, RI More by this author
Barron, RL More by this author
Gleeson, ML More by this author
Danese, MD More by this author
O'Hagan, A More by this author
Expand authors...
Journal:
PharmacoEconomics
Volume:
30
Issue:
2
Pages:
103-118
Publication date:
2012-02-05
DOI:
EISSN:
1179-2027
ISSN:
1170-7690
URN:
uuid:1e4492fa-727e-414a-acdf-c0f2b4757dcd
Source identifiers:
359099
Local pid:
pubs:359099

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP